118 related articles for article (PubMed ID: 32318747)
1. Targeting TJP1 attenuates cell-cell aggregation and modulates chemosensitivity against doxorubicin in leiomyosarcoma.
Lee EY; Yu JY; Paek AR; Lee SH; Jang H; Cho SY; Kim JH; Kang HG; Yun T; Oh SE; Park SY; You HJ
J Mol Med (Berl); 2020 May; 98(5):761-773. PubMed ID: 32318747
[TBL] [Abstract][Full Text] [Related]
2. TJP1 Contributes to Tumor Progression through Supporting Cell-Cell Aggregation and Communicating with Tumor Microenvironment in Leiomyosarcoma.
Lee EY; Kim M; Choi BK; Kim DH; Choi I; You HJ
Mol Cells; 2021 Nov; 44(11):784-794. PubMed ID: 34764231
[TBL] [Abstract][Full Text] [Related]
3. NKX6-1 mediates cancer stem-like properties and regulates sonic hedgehog signaling in leiomyosarcoma.
Su PH; Huang RL; Lai HC; Chen LY; Weng YC; Wang CC; Wu CC
J Biomed Sci; 2021 Apr; 28(1):32. PubMed ID: 33906647
[TBL] [Abstract][Full Text] [Related]
4. Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.
Maekawa A; Kohashi K; Setsu N; Kuda M; Iura K; Ishii T; Matsunobu T; Nakatsura T; Iwamoto Y; Oda Y
Cancer Sci; 2016 Jan; 107(1):95-102. PubMed ID: 26560505
[TBL] [Abstract][Full Text] [Related]
5. Tight junction protein 1 is regulated by transforming growth factor-β and contributes to cell motility in NSCLC cells.
Lee SH; Paek AR; Yoon K; Kim SH; Lee SY; You HJ
BMB Rep; 2015 Feb; 48(2):115-20. PubMed ID: 25027596
[TBL] [Abstract][Full Text] [Related]
6. A role for versican in the development of leiomyosarcoma.
Keire PA; Bressler SL; Lemire JM; Edris B; Rubin BP; Rahmani M; McManus BM; van de Rijn M; Wight TN
J Biol Chem; 2014 Dec; 289(49):34089-103. PubMed ID: 25320080
[TBL] [Abstract][Full Text] [Related]
7. Identifying and targeting cancer stem cells in leiomyosarcoma: prognostic impact and role to overcome secondary resistance to PI3K/mTOR inhibition.
Fourneaux B; Bourdon A; Dadone B; Lucchesi C; Daigle SR; Richard E; Laroche-Clary A; Le Loarer F; Italiano A
J Hematol Oncol; 2019 Jan; 12(1):11. PubMed ID: 30683135
[TBL] [Abstract][Full Text] [Related]
8. The regulatory function of miR-200c on inflammatory and cell-cycle associated genes in SK-LMS-1, a leiomyosarcoma cell line.
Chuang TD; Ho M; Khorram O
Reprod Sci; 2015 May; 22(5):563-71. PubMed ID: 25305131
[TBL] [Abstract][Full Text] [Related]
9. Copper ions are novel therapeutic agents for uterine leiomyosarcoma.
Kakuda M; Matsuzaki S; Ueda Y; Shiomi M; Matsuzaki S; Kimura T; Fujita M; Egawa-Takata T; Kobayashi E; Serada S; Yoshino K; Naka T; Kimura T
Am J Obstet Gynecol; 2020 Jan; 222(1):64.e1-64.e16. PubMed ID: 31351063
[TBL] [Abstract][Full Text] [Related]
10. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.
Zhang L; Yu D; Hicklin DJ; Hannay JA; Ellis LM; Pollock RE
Cancer Res; 2002 Apr; 62(7):2034-42. PubMed ID: 11929822
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis.
Setsu N; Kohashi K; Endo M; Yamamoto H; Tamiya S; Takahashi Y; Yamada Y; Ishii T; Matsuda S; Yokoyama R; Iwamoto Y; Oda Y
Int J Cancer; 2013 Jan; 132(1):109-15. PubMed ID: 22644781
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.
Villacis RA; Silveira SM; Barros-Filho MC; Marchi FA; Domingues MA; Scapulatempo-Neto C; Aguiar S; Lopes A; Cunha IW; Rogatto SR
PLoS One; 2014; 9(7):e102281. PubMed ID: 25028927
[TBL] [Abstract][Full Text] [Related]
13. KIF15 upregulation promotes leiomyosarcoma cell growth via promoting USP15-mediated DEK deubiquitylation.
Ge W; Chen Y; Guo Y; Zhao D; Mu L; Zhang K; Zhuo W
Biochem Biophys Res Commun; 2021 Sep; 570():117-124. PubMed ID: 34280614
[TBL] [Abstract][Full Text] [Related]
14. Tight Junction Protein 1 Dysfunction Contributes to Cell Motility in Bladder Cancer.
Tsai KW; Kuo WT; Jeng SY
Anticancer Res; 2018 Aug; 38(8):4607-4615. PubMed ID: 30061227
[TBL] [Abstract][Full Text] [Related]
15. SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells.
Zhang F; Chen A; Chen J; Yu T; Guo F
Asian Pac J Cancer Prev; 2011; 12(1):239-45. PubMed ID: 21517265
[TBL] [Abstract][Full Text] [Related]
16. PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma.
Lin ST; May EW; Chang JF; Hu RY; Wang LH; Chan HL
Cell Mol Life Sci; 2015 Jun; 72(12):2395-409. PubMed ID: 25596698
[TBL] [Abstract][Full Text] [Related]
17. TJP1, a Membrane-Expressed Protein, is a Potential Therapeutic and Prognostic Target for Lung Cancer.
Pu J; Ai T; Weng W; Wang L; Yang Y; Ma L; Hu Z; Meng X
Technol Cancer Res Treat; 2022; 21():15330338221106855. PubMed ID: 35767221
[No Abstract] [Full Text] [Related]
18. CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma.
Nakae R; Matsuzaki S; Serada S; Matsuo K; Shiomi M; Sato K; Nagase Y; Matsuzaki S; Nakagawa S; Hiramatsu K; Okazawa A; Kimura T; Egawa-Takata T; Kobayashi E; Ueda Y; Yoshino K; Naka T; Kimura T
Am J Obstet Gynecol; 2021 Feb; 224(2):197.e1-197.e23. PubMed ID: 32822640
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo.
Keire PA; Bressler SL; Mulvihill ER; Starcher BC; Kang I; Wight TN
Matrix Biol; 2016 Mar; 50():67-81. PubMed ID: 26723257
[TBL] [Abstract][Full Text] [Related]
20. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
